Biosciences Division

News

• New ORNL process brings nanoparticles into focus

  Scientists can study the biological impacts of engineered nanomaterials on cells within the body with greater resolution than ever because of a procedure developed by researchers at the Department of Energy's Oak Ridge National Laboratory.

• Audio Spot: New medicine therapeutics company is spinout from ORNL

  A Company, NellOne Therapeutics, has been formed through Battelle Ventures to research the potential for a new therapy that could help heart patients, according to Oak Ridge National Laboratory scientist Cymbeline Culiat.

Systems Genetics

The Systems Genetics Group is implementing the Collaborative Cross, a large scale mouse genetic reference population for systems genetic analysis. Experimental work focuses on complex traits related to the genomic response to low-dose radiation exposure, genotoxicity, alcoholism and drug abuse, neurodevelopment, analysis of the role of genotype in susceptibility to environmental toxicants, techniques of systems genetics analysis, informatics approaches to the integration of the mouse genome and phenome, and the cryopreservation and distribution of genetic resources to the research community.

Further details are on the website:

http://mouse.ornl.gov/

(Contact: Darla R.Miller, millerdr@ornl.gov, 865-574-0858)